• Inclusion of infections in CAR-T therapy (in Syndromes).
• Review of the prevention of infections associated with severe trauma.
• Changes in cefepime, cotrimoxazole, daptomycin, ibrexafungerp, levofloxacin, posaconazole. C. difficile, S. aureus, CMV, influenza, SARS-CoV-2. Infectious complications in ECMO, postoperative fever, healthcare-associated meningitis. STD prevention, surgical infection prophylaxis.